For primary respiratory support compared to COT.
Recommendation made with moderate certainty.
Evidence-based guidelines recommend the use of NHF for COVID-19 patients
Read about this and research related to airborne transmission.
ROX Index - a bedside tool for monitoring patients on NHF
The validated ROX index uses just 3 data points to provide an indicator of outcomes in adults with AHRF receiving NHF therapy.
A survey - the NHF systems & settings used in published research
Surveys of the studies comprising the body of NHF evidence found the majority used F&P Optiflow NHF therapy systems and flow settings between 45 and 60 L/min.